Abstract:Objective To investigate the efficacy of Qingfei Quyu decoction combined with budesonide and formoterol fumarate powder for inhalation on serum IgE and lung function in patients with bronchial asthma Methods Totally 119 patients with bronchial asthma admitted to the respiratory department of Wuhan University of Technology Hospital from April 1, 2016 to June 5, 2018 were selected and divided into control group (59 cases) and observation group (60 cases). The control group was treated with xinbikedubao inhalation; the observation group was treated with Qingfei Quyu decoction combined with xinbikedubao inhalation. The clinical efficacy, TCM syndrome score, asthma act score, serum IgE level, and lung function were compared between the two groups. Results The total effective rate of the observation group after treatment was significantly higher than that of the control group (93.33% VS. 79.66%, P < 0.05). The TCM syndrome scores and serum IgE levels of the two groups were decreased after treatment (P < 0.05), and the decrease of the observation group was more significant (P < 0.05). The ACT scores of cough and asthma control, FEV1, FEV1/FVC, and PEF levels were increased in both groups after treatment (P < 0.05), and the increase in the observation group was more significant (P < 0.05). Conclusions Qingfei Quyu decoction combined with budesonide and formoterol fumarate powder for inhalation is effective in patients with bronchial asthma, which can effectively relieve symptoms and signs, decrease serum IgE levels, reduce airway inflammation, and improve lung function.